Drug
Istradefylline OR
Istradefylline OR: highest development phase Phase 3, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Istradefylline 20 mg or 40 mg NCT02610231 | Phase 3 | Idiopathic Parkinson's Disease |
Latest
No recent events.
Follow Istradefylline OR on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.